Bright Minds Biosciences Inc (DRUG) has risen Wednesday morning, with the stock increasing 12.40% in pre-market trading to 1.45.
DRUG's short-term technical score of 37 indicates that the stock has traded less bullishly over the last month than 63% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, DRUG ranks higher than 55% of stocks.
Bright Minds Biosciences Inc has fallen 14.57% over the past month, closing at $1.40 on October 25. During this period of time, the stock fell as low as $1.21 and as high as $1.58.
DRUG has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on DRUG!
Bright Minds Biosciences Inc has a Long-Term Technical rank of 5. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 95% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, DRUG ranks better than 131% of stocks.
